NCT05307835: Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection |
|
|
| Recruiting | 1 | 40 | RoW | iNeo-Vac-P01, Neoantigen peptides, GM-CSF, immune adjuvant, granulocyte-macrophage colony stimulating factor | Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou Neoantigen Therapeutics Co., Ltd. | Resectable Esophageal Cancer | 12/25 | 12/25 | | |
NCT04672889: Use Babyguard® Breast Milk Probiotics to Verify the Authenticity of the Gut-Breast Axis Hypothesis |
|
|
| Completed | N/A | 30 | RoW | Placebo, Babyguard® Breast Milk Probiotics | TCI Co., Ltd. | Intestinal Bacteria Flora Disturbance | 09/24 | 11/24 | | |